MyChesCo on MSN2 天
Windtree Therapeutics Highlights Promising Phase 2b Results for Istaroxime
Windtree Therapeutics, Inc. (NasdaqCM: WINT) showcased encouraging results from the Phase 2b SEISMiC study of istaroxime, its novel investigational therapy for early cardiogenic shock, at the ...
Live Science on MSN4 天
100-year-old heart drug made from foxglove may help 'dissolve' clumps of spreading cancer cells
The heart drug digoxin could potentially be combined with existing cancer therapies to prevent the spread of tumors, an early ...